# Effect of Spironolactone in Treating Chronic Non-resolutive Central Serous Chorioretinitis

> **NCT01552044** · PHASE1,PHASE2 · COMPLETED · sponsor: **Institut National de la Santé Et de la Recherche Médicale, France** · enrollment: 17 (actual)

## Conditions studied

- Central Serous Chorioretinitis

## Interventions

- **DRUG:** Spironolactone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01552044
- **Lead sponsor:** Institut National de la Santé Et de la Recherche Médicale, France
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-01
- **Final completion:** 2013-02
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2025-08-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01552044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01552044, "Effect of Spironolactone in Treating Chronic Non-resolutive Central Serous Chorioretinitis". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT01552044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*